Portal Hypertension
227
36
41
86
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
16 trials with published results (7%)
Research Maturity
86 completed trials (38% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
10 terminated out of 227 trials
89.6%
+3.1% vs benchmark
16%
36 trials in Phase 3/4
19%
16 of 86 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 86 completed trials
Clinical Trials (227)
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Ultrasound Prediction of Esophageal Variceal Bleeding Risk
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
Freiburg TIPS Registry
Early TIPS in Patients With Liver Cirrhosis and Ascites
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation
4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement
EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Non-invasive Predictors of Esophageal Varices and Their Correlation to Upper Endoscopic Findings
EUS Guided Portal-systemic Pressure Gradient Measurement
Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study
Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
Construction of a Portal Hypertension Biobank
Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension